Electroid 7 Vaccine

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D Bacterin-Toxoid

Electroid 7 Vaccine Indications

For the vaccination of healthy cattle against diseases caused by Clostridium chauvoei, Cl. septicum, Cl. sordellii, Cl. novyi Type B and Cl. perfringens Types C and D.

Although Clostridium perfringens Type B is not a significant problem in the USA, immunity may be provided against the beta and epsilon toxins elaborated by Cl. perfringens Type B. This immunity is derived from the combination of Type C (beta) and Type D (epsilon) fractions.

Electroid 7 Vaccine Caution

Store at 35°-45°F (2°-7°C). Protect from freezing. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use.

Antidote

Administration And Dosage

Shake well. Using aseptic technique, inject subcutaneously or intramuscularly. Dosage: 5 mL, repeated in 3 to 4 weeks. Revaccinate annually with 5 mL prior to periods of extreme risk, or parturition. For Cl. novyi, revaccinate every 5 to 6 months. Animals vaccinated under 3 months of age should be revaccinated at weaning or 4 to 6 months of age.

Precautions

This product has been tested under laboratory conditions and has met all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions. Local reactions may be observed following subcutaneous administration to cattle.

Copyright ©1997

Schering-Plough Animal Health Corp., Omaha, NE 68103 U.S.A.

Manufactured by SCHERING-PLOUGH ANIMAL HEALTH LIMITED, UPPER HUTT, NEW ZEALAND

Distributed by SCHERING-PLOUGH ANIMAL HEALTH CORP., OMAHA, NE 68103 U.S.A.

U.S. Veterinary Permit No. 311

For veterinary use only

Nac No.